Last 1,310 INR
Change Today 0.00 / 0.00%
Volume 0.0
CDH On Other Exchanges
Symbol
Exchange
Natl India
As of 7:05 AM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

cadila healthcare ltd (CDH) Snapshot

Open
1,319
Previous Close
1,322
Day High
1,330
Day Low
1,061
52 Week High
09/30/14 - 1,359
52 Week Low
10/29/13 - 648.00
Market Cap
268.2B
Average Volume 10 Days
115.2K
EPS TTM
39.25
Shares Outstanding
204.7M
EX-Date
07/17/14
P/E TM
33.4x
Dividend
9.00
Dividend Yield
0.69%
Current Stock Chart for CADILA HEALTHCARE LTD (CDH)

Related News

No related news articles were found.

cadila healthcare ltd (CDH) Related Businessweek News

No Related Businessweek News Found

cadila healthcare ltd (CDH) Details

Cadila Healthcare Limited discovers, develops, manufactures, and markets a range of healthcare products worldwide. It provides its products in various forms, including formulations, injectable, aerosols, ointments, vaccines, biologics, active pharmaceutical ingredients, etc. The company offers products in the areas of cardiovascular, gastro intestinal, respiratory, women’s healthcare, pain management, CNS, anti-infective, oncology, neuroscience, dermatology, nephrology, and chronic/lifestyle primarily under the Aten, Ocid, Deriphyllin, Pantodac, Atorva, Nucoxia, and Mifegest brands. It also provides consumer healthcare and wellness products, such as Sugar Free Gold, a sweetener; Sugar Free Natura, a sucralose based sugar substitute; Sugar Free D’lite, a healthy drink; Nutralite, a cholesterol-free table spread; and Actilife, a nutritional milk additive for adults, as well as skincare products comprising scrubs, peel-off, face wash, and soaps under its Everyuth and Dermacare brands. In addition, the company researches and develops a pipeline of 19 biologics comprising 17 biosimilars and 2 novel biological products; new drugs in cardio-metabolic, inflammation, pain, and oncology therapeutic areas; novel drug delivery systems; molecules for DMF filing and NPD molecules; and generic products, as well as solid orals, pulmonary, parenterals, suppository, topical, and oncology products. Further, it provides animal healthcare products comprising drugs, feed supplements, and vaccines for livestock, companion animals, and poultry. Additionally, the company develops vaccines that are designed to address infectious diseases, including next-generation influenza, measles-mumps-rubella-varicella, typhoid, DPT-HiB, hepatitis-B, hepatitis-A, hepatitis-E, Japanese encephalitis, and HPV. It has strategic out-licensing deal with Abbott Laboratories for the commercial supply of products. The company was founded in 1952 and is headquartered in Ahmedabad, India.

Founded in 1952

cadila healthcare ltd (CDH) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

cadila healthcare ltd (CDH) Key Developments

Zydus Cadila Receives Tentative Approval for Glipizide ER Tablets

Zydus Cadila has received tentative approval from the USFDA to market Glipizide Extended release tablets in the strengths of 2.5 mg, 5 mg, and 10 mg. The drug falls in the ant-diabetic segment.

Zydus Receives Final Approval for Acyclovir Tablets

Zydus Cadila has received the final approval from the US FDA to market Acyclovir Tablets in the strengths of 400 mg and 800 mg. The drug falls under the anti-viral segment.

Cadila Healthcare Limited Approves Dividend for the Fiscal Year 2014

Cadila Healthcare Limited announced at AGM held on July 30, 2014, the shareholders of the company approved a dividend of INR 9.00 or 180% per equity share for the fiscal year 2014, aggregating to INR 1,842,736,680 on 204,748,520 equity shares of INR 5 each, the dividend shall be made payable to those shareholders of the company whose names appear in the register of members of the company on July 30, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CDH:IN 1,309.70 INR 0.00

CDH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ipca Laboratories Ltd 783.70 INR -8.25
Piramal Enterprises Ltd 752.70 INR -13.75
Ranbaxy Laboratories Ltd 638.40 INR -1.30
Torrent Pharmaceuticals Ltd 884.50 INR +13.05
Wockhardt Ltd 806.20 INR +7.25
View Industry Companies
 

Industry Analysis

CDH

Industry Average

Valuation CDH Industry Range
Price/Earnings 30.7x
Price/Sales 3.4x
Price/Book 7.6x
Price/Cash Flow 24.4x
TEV/Sales 3.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CADILA HEALTHCARE LTD, please visit www.zyduscadila.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.